William P.D. Hendricks

Glioblastoma and Other Malignant Gliomas

Long Noncoding RNAs in Cancer Pathways

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

Monosomy of Chromosome 10 Associated With Dysregulation of Epidermal Growth Factor Signaling in Glioblastomas

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Neutrophils in cancer: neutral no more

Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression

Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression

GSK-3 as potential target for therapeutic intervention in cancer

Esterase‐Activated Charge‐Reversal Polymer for Fibroblast‐Exempt Cancer Gene Therapy

Long Noncoding RNA and Cancer: A New Paradigm

Answering the ultimate question “What is the Proximal Cause of Aging?”

Correlative imaging of ionic transport and electronic structure in nano Li_0.5FePO₄ electrodes

Nanotechnology for Multimodal Synergistic Cancer Therapy

Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells

Chemotherapy induces enrichment of CD47 ⁺ /CD73 ⁺ /PDL1 ⁺ immune evasive triple-negative breast cancer cells

Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain

Diagnostic and prognostic significance of genetic regional heterogeneityin meningiomas

Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue

A nanoparticle formulation that selectively transfects metastatic tumors in mice

PI3Kα Inhibitors That Inhibit Metastasis